Medical technology company Asker Healthcare Group reported increased revenue and adjusted EBITA in the first quarter compared to the same period last year.

Net sales rose 13.2 percent to SEK 4,521 million (3,995). Organic sales growth was 5 percent (6).

EBITA amounted to SEK 428 million (311), with an EBITA margin of 9.5 percent (7.8).

Adjusted EBITA reached SEK 442 million (364). Organic growth was 8 percent.

'Growth and margin expansion are built on a stable and broad foundation with solid performance across all regions. It is the combination of strong sales development, ongoing efficiency improvements, and economies of scale that is driving organic development', commented CEO Johan Falk.

Operating profit was SEK 310 million (237), with an operating margin of 6.9 percent (5.9).

Profit after tax amounted to SEK 197 million (95), and earnings per share were SEK 0.50 (0.19).

Cash flow from operating activities totaled SEK 419 million (109).

Asker, SEKmQ1-2026Q1-2025Change
Net sales4,5213,99513.2%
Organic sales growth, percent56-16.7%
EBITA42831137.6%
EBITA margin9.5%7.8%
Adjusted EBITA44236421.4%
Adjusted EBITA margin9.8%9.1%
Operating profit31023730.8%
Operating margin6.9%5.9%
Net profit19795107.4%
Earnings per share, SEK0.500.19163.2%
Cash flow from operating activities419109284.4%